How Lantern Pharma's AI Is Changing the Game
The precision oncology medicine company guided three drugs in the trial pipeline with uncommon efficiency.
Source: dmagazine.com
Response Algorithm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Response Algorithm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Response Algorithm Today - Breaking & Trending Today
Lantern Pharma Announces Collaboration & Research Agreement with The Danish Cancer Society Research Center to Support Clinical Development of Drug Candidates, LP-100 and LP-184, in Solid Tumors
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
Source: prnewswire.com
Lantern Pharma Collaborating With Danish Cancer Research Center on Drugs for NER-Deficient Tumors
They will use expanded mutational signature analyses to identify new biomarker-defined indications in multiple tumor types.
Source: precisiononcologynews.com
Lantern Pharma Expands Precision Oncology Collaboration with the National Cancer Institute - Accelerating Path to First in Human Clinical Trials for Drug Candidates LP-184 & LP-284
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
Source: prnewswire.com
Lantern Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
Source: prnewswire.com